RGD-DA6 is an alphavbeta3-targeting ligand composed of RGDfK (an RGD peptide targeting integrin alphavbeta3), DOTADG, d-Glu, Lys, AMBA, and IPBA. Through radiolabeling, RGD-DA6 forms an alphavbeta3-targeted radioligand for high-contrast tumor imaging and improved anticancer efficacy.
Target:
Integrin
* VAT and and shipping costs not included. Errors and price changes excepted
